ClinicalTrials.gov
public full text
Public Domain
Phase I Study in RAD 001 Patients With Relapse AML
A phase I clinical study in evaluation of RAD 001 with aracytine and daunorubicine in AML treatment of patients older less than 65 years in relapse
Conceptio Open Archive
Analyze & explore related research in Conceptio
Connect this record directly into your research workflow or AI agent. Explore citations across open repositories, query full text, and export structured proof bundles.
This document is indexed with metadata only: full text is not available in the archive for this record. Open the official source ↗
Related documents
- Rapamycin in Combination With Low-dose Aracytin in Elderly Acute Myeloid Leukemia Patients#881557
- Pharmacoscopy-guided Clinical Standard-of-care in r/r AML#854501
- BST-236 as a Single Agent in Adults With Relapsed or Refractory AML or HR-MDS#864243
- Efficacy of FLAG Regimen for the Treatment of Patients With AML#1127539
- Safety and Efficacy Study of Ara-c at 18 gm/m2 Versus 12 gm/m2 for 3 Cycles Each in AML Consolidation#877917
Record · ID 1173107
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Bring this data into your agent: Connect via MCP or API · 20 free credits to start · no card required
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive